科研之友
微信
新浪微博
Facebook
分享链接
摘要
<正>At a time of unprecedented need and despite significant advances in understanding brain function and related diseases,the drug pipeline for treatment of mental ill-health is failing[1,2]. The reasons are many, including the unparalleled complexity of the central nervous system (CNS) itself, a lack of interdisciplinary research collaborations, increased drug development costs,
